Sponsor:
Theralase® Technologies Inc.
Code:
NCT03945162
Conditions
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ruvidar® (TLD-1433) Bladder infusion and PDT
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations